• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Serotype determinant protein of Neisseria Meningitidis. Large scale preparation by direct detergent treatment of the bacterial cells.

作者信息

Helting T B, Guthöhrlein G, Blackkolb F, Ronneberger H

出版信息

Acta Pathol Microbiol Scand C. 1981 Apr;89(2):69-78.

PMID:6794337
Abstract

Neisseria meningitidis Group B microorganisms, inactivated with phenol and harvested by centrifugation, were subjected to direct treatment with various detergents to solubilize the serotype determinant proteins localized in the outer membrane. Analysis of the data showed that extraction of the cells with detergents provided yields of the serotype protein substantially exceeding those obtained by simple salt extraction of the bacteria. Routinely, more than 2 mg of end product per g of cell mass (wet weight) may be recovered by the present method. By gel chromatographic analysis, the serotype determinant protein was shown to interact with the capsular polysaccharides derived from Group A or C Neisseria meningitidis microorganisms, forming high molecular weight complexes. This interaction markedly enhanced the solubility of the serotype determinant protein. Combined vaccines of the type-specific protein with the group- specific polysaccharides were evaluated for their immunogenic potential in the subcutaneous steel spring implant model. In guinea pigs, amounts corresponding to 10 micrograms completely prevented infection upon challenge with homologous organisms four weeks after immunization. Partial protection was observed with immunizing doses corresponding to 2 micrograms or 0.4 micrograms/animal, respectively. Compared to lyophilized preparations, vaccines adsorbed to a mineral carrier were slightly less effective in inducing protection, whereas inclusion of Bordetella pertussis as a component of the vaccine stimulated the immune response.

摘要

相似文献

1
Serotype determinant protein of Neisseria Meningitidis. Large scale preparation by direct detergent treatment of the bacterial cells.
Acta Pathol Microbiol Scand C. 1981 Apr;89(2):69-78.
2
Effect of aluminium hydroxide and meningococcal serogroup C capsular polysaccharide on the immunogenicity and reactogenicity of a group B Neisseria meningitidis outer membrane vesicle vaccine.氢氧化铝和C群脑膜炎球菌结合多糖对B群脑膜炎奈瑟菌外膜囊泡疫苗免疫原性和反应原性的影响。
Dev Biol Stand. 1998;92:323-33.
3
Protection against group B Neisseria meningitidis disease: preparation of soluble protein and protein-polysaccharide immunogens.针对B群脑膜炎奈瑟菌疾病的防护:可溶性蛋白和蛋白-多糖免疫原的制备。
Infect Immun. 1982 Jul;37(1):271-80. doi: 10.1128/iai.37.1.271-280.1982.
4
Protection against group B meningococcal disease. III. Immunogenicity of serotype 2 vaccines and specificity of protection in a guinea pig model.预防B群脑膜炎球菌病。III. 2型疫苗在豚鼠模型中的免疫原性及保护特异性。
J Exp Med. 1978 Mar 1;147(3):629-44. doi: 10.1084/jem.147.3.629.
5
Immunization with meningococcal outer-membrane protein vesicles containing lipooligosaccharide protects mice against lethal experimental group B Neisseria meningitidis infection and septic shock.用含有脂寡糖的脑膜炎球菌外膜蛋白囊泡进行免疫接种可保护小鼠免受致死性B群脑膜炎奈瑟菌感染和败血性休克。
J Infect Dis. 1999 Sep;180(3):747-54. doi: 10.1086/314927.
6
Elevated levels of maternal anti-tetanus toxin antibodies do not suppress the immune response to a Haemophilus influenzae type b polyribosylphosphate-tetanus toxoid conjugate vaccine.母体抗破伤风毒素抗体水平升高不会抑制对b型流感嗜血杆菌多聚核糖磷酸-破伤风类毒素结合疫苗的免疫反应。
Bull World Health Organ. 2000;78(3):364-71.
7
Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different neisseria meningitidis serogroup C conjugate vaccines.10价肺炎球菌非分型流感嗜血杆菌蛋白D结合疫苗(PHiD-CV)与不同的脑膜炎奈瑟菌C群结合疫苗同时接种时的免疫原性。
Pediatr Infect Dis J. 2009 Apr;28(4 Suppl):S77-88. doi: 10.1097/INF.0b013e318199f609.
8
Intranasal immunization of mice with recombinant lipidated P2086 protein reduces nasal colonization of group B Neisseria meningitidis.用重组脂化P2086蛋白对小鼠进行鼻内免疫可减少B群脑膜炎奈瑟菌的鼻腔定植。
Vaccine. 2006 Jun 29;24(26):5420-5. doi: 10.1016/j.vaccine.2006.03.051. Epub 2006 Mar 31.
9
A conjugate vaccine composed of a heat shock protein 60 T-cell epitope peptide (p458) and Neisseria meningitidis type B capsular polysaccharide.一种由热休克蛋白60 T细胞表位肽(p458)和B型脑膜炎奈瑟菌荚膜多糖组成的结合疫苗。
Vaccine. 2006 Oct 30;24(42-43):6555-63. doi: 10.1016/j.vaccine.2006.06.019. Epub 2006 Jun 27.
10
Immunoproteomic identification of the hypothetical protein NMB1468 as a novel lipoprotein ubiquitous in Neisseria meningitidis with vaccine potential.免疫蛋白质组学鉴定假定蛋白NMB1468为新型脂蛋白,该蛋白在脑膜炎奈瑟菌中普遍存在且具有疫苗潜力。
Proteomics. 2008 May;8(10):2115-25. doi: 10.1002/pmic.200700574.

引用本文的文献

1
Product review on the IMD serogroup B vaccine Bexsero®.关于 IMD 血清群 B 疫苗 Bexsero®的产品评价。
Hum Vaccin Immunother. 2022 Dec 31;18(1):2020043. doi: 10.1080/21645515.2021.2020043. Epub 2022 Feb 22.
2
Bexsero® chronicle.贝克斯洛(Bexsero®)纪事
Pathog Glob Health. 2014 Oct;108(7):305-16. doi: 10.1179/2047773214Y.0000000162.
3
Vaccines against meningococcal serogroup B disease containing outer membrane vesicles (OMV): lessons from past programs and implications for the future.针对 B 群脑膜炎球菌疾病的疫苗含有外膜囊泡 (OMV):过去计划的经验教训及对未来的启示。
Hum Vaccin Immunother. 2013 Jun;9(6):1241-53. doi: 10.4161/hv.24129. Epub 2013 Mar 7.
4
Distribution of serotypes of Neisseria meningitidis in the Federal Republic of Germany, 1979-1981.1979 - 1981年德意志联邦共和国脑膜炎奈瑟菌血清型分布情况
Med Microbiol Immunol. 1982;171(3):145-9. doi: 10.1007/BF02123622.
5
Protection against group B Neisseria meningitidis disease: effect of serogroup B polysaccharide and polymyxin B on immunogenicity of serotype protein preparations.预防B群脑膜炎奈瑟菌病:B群多糖和多粘菌素B对血清型蛋白制剂免疫原性的影响。
Infect Immun. 1982 Jul;37(1):264-70. doi: 10.1128/iai.37.1.264-270.1982.
6
Importance of complement source in bactericidal activity of human antibody and murine monoclonal antibody to meningococcal group B polysaccharide.补体来源在人源抗体及抗B群脑膜炎球菌多糖鼠单克隆抗体杀菌活性中的重要性
Infect Immun. 1983 Apr;40(1):257-64. doi: 10.1128/iai.40.1.257-264.1983.
7
Immunogenicity of conjugate vaccines consisting of pneumococcal capsular polysaccharide types 6B, 14, 19F, and 23F and a meningococcal outer membrane protein complex.由肺炎球菌6B型、14型、19F型和23F型荚膜多糖与脑膜炎球菌外膜蛋白复合物组成的结合疫苗的免疫原性。
Infect Immun. 1992 Dec;60(12):4977-83. doi: 10.1128/iai.60.12.4977-4983.1992.